Login / Signup

Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia.

Zhenhong DengJingru JiangJia WangDong PanYingying ZhuHonghong LiXiaoni ZhangXiaohuan LiuYongteng XuYi LiYamei Tangnull null
Published in: Hypertension (Dallas, Tex. : 1979) (2022)
In patients with hypertension and mild cognitive impairment, angiotensin receptor blockers were associated with a lower risk of progression to dementia compared with ACE inhibitors and other classes of AHMs. Our findings may have important implications for clinical practice but still warrant further investigations in larger prospective cohorts or clinical trials.
Keyphrases
  • mild cognitive impairment
  • angiotensin converting enzyme
  • angiotensin ii
  • cognitive decline
  • clinical trial
  • clinical practice
  • blood pressure
  • randomized controlled trial
  • phase ii
  • phase iii